Dallas-based biotech Colossal Biosciences is racing to revive the woolly mammoth by 2028, using advanced gene-editing and de-extinction science. Co-founded by Ben Lamm and Harvard geneticist George Church, the startup believes reintroducing the species could help restore Arctic ecosystems and change how technology tackles biodiversity loss in the modern age.